Press releases - 2024

Domain Therapeutics strengthens its intellectual property for its series of Treg depleting anti-CCR...

Domain Therapeutics appoints Sean A. MacDonald as Chief Executive Officer

Domain Therapeutics to participate at premier investor and healthcare conferences

Domain Therapeutics to present latest data on DT-9045, a first-in-class Negative Allosteric Modulat...

Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 ...

Domain Therapeutics promotes Stephan Schann as Chief Scientific Officer (CSO)

Domain Therapeutics further strengthens leadership team with appointment of Sean A. MacDonald as Ch...

Domain Therapeutics awarded Hospital-University Research in Health (RHU) SPRINT consortium grant to ...

Domain Therapeutics strengthens leadership team to spearhead global development and North American e...